Detalhe da pesquisa
1.
Breast Cancer Polygenic Risk Score and Contralateral Breast Cancer Risk.
Am J Hum Genet
; 107(5): 837-848, 2020 11 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-33022221
2.
Breast cancer and cardiovascular outcomes after breast cancer in survivors of Hodgkin lymphoma.
Cancer
; 128(24): 4285-4295, 2022 12 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-36281718
3.
Comprehensive trends in incidence, treatment, survival and mortality of first primary invasive breast cancer stratified by age, stage and receptor subtype in the Netherlands between 1989 and 2017.
Int J Cancer
; 148(9): 2289-2303, 2021 05 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-33252836
4.
Prediction of contralateral breast cancer: external validation of risk calculators in 20 international cohorts.
Breast Cancer Res Treat
; 181(2): 423-434, 2020 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-32279280
5.
Prediction and clinical utility of a contralateral breast cancer risk model.
Breast Cancer Res
; 21(1): 144, 2019 12 17.
Artigo
em Inglês
| MEDLINE | ID: mdl-31847907
6.
Effectief rookstopprogramma in Almere.
Huisarts Wet
; 66(4): 30-32, 2023.
Artigo
em Holandês
| MEDLINE | ID: mdl-37008743
7.
Risk of death due to COVID-19 among current and former smokers in the Netherlands: a population-based quasi-cohort study.
Int J Epidemiol
; 53(1)2024 Feb 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-38302746
8.
The use of patient sitters at a Swiss hospital: A retrospective observational study.
PLoS One
; 18(6): e0287317, 2023.
Artigo
em Inglês
| MEDLINE | ID: mdl-37315098
9.
Risk of metachronous contralateral breast cancer in patients with primary invasive lobular breast cancer: Results from a nationwide cohort.
Cancer Med
; 12(3): 3123-3133, 2023 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-36127572
10.
Contralateral breast cancer risk in patients with ductal carcinoma in situ and invasive breast cancer.
NPJ Breast Cancer
; 6(1): 60, 2020 Nov 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-33298933
11.
The Influence of Adjuvant Systemic Regimens on Contralateral Breast Cancer Risk and Receptor Subtype.
J Natl Cancer Inst
; 111(7): 709-718, 2019 07 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-30698719